Terms: = Liver cancer AND SPOP, TEF2, 8405, ENSG00000121067, O43791 AND Treatment
6 results:
1. CSN6-spop-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation.
Li K; Zhang J; Lyu H; Yang J; Wei W; Wang Y; Luo H; Zhang Y; Jiang X; Yi H; Wang M; Zhang C; Wu K; Xiao L; Wen W; Xu H; Li G; Wan Y; Yang F; Yang R; Fu X; Qin B; Zhou Z; Zhang H; Lee MH
Adv Sci (Weinh); 2024 Apr; 11(14):e2306827. PubMed ID: 38308184
[TBL] [Abstract] [Full Text] [Related]
2. spop promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer.
Gong DA; Zhou P; Chang WY; Yang JY; Zhang YL; Huang AL; Tang N; Wang K
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119642. PubMed ID: 37996058
[TBL] [Abstract] [Full Text] [Related]
3. O-GlcNAcylation of spop promotes carcinogenesis in hepatocellular carcinoma.
Zhou P; Chang WY; Gong DA; Huang LY; Liu R; Liu Y; Xia J; Wang K; Tang N; Huang AL
Oncogene; 2023 Mar; 42(10):725-736. PubMed ID: 36604567
[TBL] [Abstract] [Full Text] [Related]
4. Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate cancer.
Feng E; Rydzewski NR; Zhang M; Lundberg A; Bootsma M; Helzer KT; Lang JM; Aggarwal R; Small EJ; Quigley DA; Sjöström M; Zhao SG
Clin Cancer Res; 2022 Dec; 28(24):5396-5404. PubMed ID: 36260524
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate cancer.
Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
[TBL] [Abstract] [Full Text] [Related]
6. The emerging role of spop protein in tumorigenesis and cancer therapy.
Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
[TBL] [Abstract] [Full Text] [Related]
